Literature DB >> 29046801

Outcome of decompression using a transnasal ileus tube in malignant adhesive bowel obstruction: A retrospective study.

Xiang-Jun Han1, Fan Zhao1, Hong-Ying Su1, Ke Xu1.   

Abstract

Malignant adhesive bowel obstruction caused by peritoneal carcinomatosis is a common complication of advanced abdominal malignancies, and surgical treatment provides little benefit. The present study was undertaken to evaluate the decompression efficacy of a transnasal ileus tube under X-ray guidance, with benign adhesive bowel obstruction patients serving as the control group. A total of 21 patients with malignant adhesive bowel obstruction and 60 patients with benign conditions were enrolled between February 2011 and March 2015. All the patients were treated with transnasal ileus intubation under X-ray guidance. A total of 9 of the 21 malignant cases and 44 of the 60 benign cases were successfully treated with transnasal ileus intubation (42.9 vs. 73.3%, respectively; P=0.01). Treatment in 8 malignant and 4 benign cases failed due to death, tube discharge, and/or therapy abandonment, all of which contributed to a significant difference between the two groups (38.1 vs. 6.7%, respectively; P=0.01). A total of 4 malignant cases and 12 benign adhesion cases received further surgical treatment, the success rate of which was 50 vs. 91.7%, respectively. The rate of successfully treated intubation cases in all resolution patients was similar between the two groups (81.8% in the malignant group and 80% in the benign group; P=0.89). In conclusion, ileus tube decompression in patients with malignant conditions was associated with a lower success rate and lower further surgical intervention success rate compared with that observed in patients with benign conditions. However, insertion of an ileus tube may successfully cure ~80% of all resolution patients in both groups; thus, it may be used as a feasible therapy in malignant adhesive bowel obstruction patients, similar to patients with benign obstruction.

Entities:  

Keywords:  adhesive bowel obstruction; ileus tube; intestinal decompression; malignant bowel obstruction; peritoneal carcinomatosis

Year:  2017        PMID: 29046801      PMCID: PMC5639277          DOI: 10.3892/mco.2017.1382

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  23 in total

Review 1.  Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee.

Authors:  D J Feuer; K E Broadley; J H Shepherd; D P Barton
Journal:  Gynecol Oncol       Date:  1999-12       Impact factor: 5.482

2.  Subtotal colectomy vs. intraoperative colonic irrigation in the management of obstructed left colon carcinoma.

Authors:  J A Torralba; R Robles; P Parrilla; J A Lujan; R Liron; A Piñero; J A Fernandez
Journal:  Dis Colon Rectum       Date:  1998-01       Impact factor: 4.585

3.  Results of surgery for obstructing carcinomatosis of gastrointestinal, pancreatic, or biliary origin.

Authors:  A D Turnbull; J Guerra; H F Starnes
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

4.  Outcome prognostic factors in inoperable malignant bowel obstruction.

Authors:  Margarita Romeo; Maria de Los LLanos Gil; José Luís Cuadra Urteaga; Laia Vilà; Sara Ahlal; Alberto Indacochea; Núria Pardo; Joaquim Radua; Albert Font; Albert Tuca
Journal:  Support Care Cancer       Date:  2016-06-10       Impact factor: 3.603

5.  Early postoperative small bowel obstruction.

Authors:  J C Quatromoni; L Rosoff; J M Halls; A E Yellin
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

Review 6.  Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.

Authors:  D J Feuer; K E Broadley
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Challenges and outcome of surgery for bowel obstruction in women with gynaecologic cancer.

Authors:  Bjorg Furnes; Rune Svensen; Harald Helland; Kjell Ovrebo
Journal:  Int J Surg       Date:  2016-02-04       Impact factor: 6.071

8.  Management and survival of patients affected with obstructive colorectal cancer.

Authors:  P Barillari; P Aurello; R De Angelis; S Valabrega; G Ramacciato; F D'Angelo; G Fegiz
Journal:  Int Surg       Date:  1992 Oct-Dec

Review 9.  Malignant obstruction of the left colon.

Authors:  G T Deans; Z H Krukowski; S T Irwin
Journal:  Br J Surg       Date:  1994-09       Impact factor: 6.939

10.  Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution.

Authors:  Albert Tuca; Ernest Guell; Emilio Martinez-Losada; Nuria Codorniu
Journal:  Cancer Manag Res       Date:  2012-06-13       Impact factor: 3.989

View more
  4 in total

1.  Strategy to small intestine obstruction caused by Crohn's disease on the basis of transnasal ileus tube insertion.

Authors:  Lingyun Zuo; Lei Cao; Chengliang Ding; Hongfei Tu; Cheng Wei; Lili Yuan; Huali Wang; Bin Zhang
Journal:  BMC Surg       Date:  2022-05-14       Impact factor: 2.030

2.  New insertion method of transnasal ileus tube for small bowel obstruction: Anterior balloon method.

Authors:  Daisuke Yamaguchi; Kei Ikeda; Yuki Takeuchi; Rikako Kinoshita; Toru Higuchi; Hiroko Fukuda; Naoyuki Tominaga; Tomohito Morisaki; Keisuke Ario; Seiji Tsunada; Hisako Yoshida; Kazuma Fujimoto
Journal:  PLoS One       Date:  2018-11-21       Impact factor: 3.240

3.  Clinical characteristics of nasointestinal ileus tube-induced intussusception: three case reports and a literature review.

Authors:  Lin Zhu; Yi Xiong Zheng; Kai Bo Chen
Journal:  J Int Med Res       Date:  2019-12-25       Impact factor: 1.671

4.  Who would avoid severe adverse events from nasointestinal tube in small bowel obstruction? A matched case-control study.

Authors:  Hui Wang; Jun-Rong Zhang; Shuai Chen; Ping Hou; Qing-Feng Chen; Zong-Qi Weng; Xin-Chang Shang-Guan; Bing-Qiang Lin; Xian-Qiang Chen
Journal:  BMC Gastroenterol       Date:  2022-07-07       Impact factor: 2.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.